← FDA Drug Approvals (Drugs@FDA)
PREGABALIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CADILA PHARMS LTD · Approved 2023-07-12
Drug application
- FDA Application #
ANDA206452- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PREGABALIN
- Generic name
- PREGABALIN
- Active ingredients
- PREGABALIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- CADILA PHARMS LTD
- Manufacturer
- Cadila Pharmaceuticals Limited
- First approval
- 2023-07-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown